comparemela.com

Latest Breaking News On - News ratings for acurx pharmaceuticals daily - Page 3 : comparemela.com

Acurx Pharmaceuticals, Inc (NASDAQ:ACXP) Short Interest Update

Acurx Pharmaceuticals, Inc (NASDAQ:ACXP) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Short Interest in Acurx Pharmaceuticals, Inc (NASDAQ:ACXP) Grows By 50 7%

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 10,100 shares, an increase of 50.7% from the September 15th total of 6,700 shares. Currently, 0.1% of the company’s shares are sold short. […]

Acurx Pharmaceuticals, Inc (NASDAQ:ACXP) Short Interest Update

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 6,700 shares, a drop of 51.1% from the August 31st total of 13,700 shares. Based on an average daily volume of 35,000 shares, the days-to-cover ratio […]

Acurx Pharmaceuticals, Inc (NASDAQ:ACXP) Sees Large Growth in Short Interest

Acurx Pharmaceuticals, Inc (NASDAQ:ACXP) Sees Large Growth in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Comparing Acurx Pharmaceuticals (NASDAQ:ACXP) & vTv Therapeutics (NASDAQ:VTVT)

Acurx Pharmaceuticals (NASDAQ:ACXP – Get Free Report) and vTv Therapeutics (NASDAQ:VTVT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership. Analyst Recommendations This is a summary of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.